Evidence map›Paper›PMID 38619690›Full record

ReviewCurrent heart failure reports2024

Putting More Weight on Obesity Trials in Heart Failure.

Josephine Harrington, Naveed Sattar, G Michael Felker, James L Januzzi, Carolyn S P Lam, Neha J Pagidipati, Ambarish Pandey, Harriette G C Van Spall, Darren K McGuire

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current heart failure reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. STEP HFpEF DM: a sweet sequel.Heart failure reviews · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 4 countries.

Josephine HarringtonDivision of Cardiology, Department of Internal Medicine, Duke University Medical Center, Durham, NC, USA. josephine.harrington@duke.edu.
Naveed SattarSchool of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
G Michael FelkerDivision of Cardiology, Department of Internal Medicine, Duke University Medical Center, Durham, NC, USA.
James L JanuzziBaim Institute for Clinical Research, Boston, MA, USA.
Carolyn S P LamCardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Neha J PagidipatiDivision of Cardiology, Department of Internal Medicine, Duke University Medical Center, Durham, NC, USA.
Ambarish PandeyDivision of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Harriette G C Van SpallBaim Institute for Clinical Research, Boston, MA, USA.
Darren K McGuireDivision of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Baim Institute for Clinical Research · USDuke Medical Center · USThe University of Texas Southwestern Medical Center · USClinical Research Institute · USNational Heart Centre Singapore · SGUniversity of Glasgow · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewTo review ongoing and planned clinical trials of weight loss among individuals with or at high risk of heart failure. RECENT

findingsIntentional weight loss via semaglutide among persons with heart failure and preserved ejection fraction and obesity significantly improves weight loss and health status as assessed by the KCCQ-CSS score and is associated with improvements in 6-min walk test. Ongoing and planned trials will explore the role of intentional weight loss with treatments such as semaglutide or tirzepatide for individuals with heart failure across the entire ejection fraction spectrum.

Indexed as

Heart FailureObesityWeight LossClinical Trials as TopicHumansStroke VolumeClinical trialHeart failureObesityWeight loss

Identifiers

PMID38619690
OpenAlexW4394812762

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.